Currently, AIDS or severe immunodeficiency remains as a challenge for people with HIV
(PWHIV) and healthcare providers. Our purpose was to analyze the impact of advanced HIV …

Background: Terms and criteria to classify people living with HIV on antiretroviral therapy
who fail to achieve satisfactory CD4+ T-cell counts are heterogeneous, and need revision …

Background Studies in adults and children suggested that starting antiretroviral therapy
(ART) soon after infection positively influences early events in HIV infection raising the …

Background and Purpose: We determined the diagnostic accuracy of the Montreal Cognitive
Assessment (MoCA) for poststroke neurocognitive disorder defined according to the …

Background Data on SARS-CoV-2 mRNA vaccine immunogenicity in people living with
human immunodeficiency virus (PLWH) and discordant immune response (DIR) are …

Background Human immunodeficiency virus (HIV)–infected immunological nonresponders
(INRs) fail to reconstitute their CD4+ T-cell pool after initiation of antiretroviral therapy, and …

The association between gut microbiota and immunologic nonresponse among people
living with HIV (PLHIV) on antiretroviral therapy (ART) is not well documented. This study …

Poor immunological responders (PIR) are HIV-infected patients with virologic suppression
upon antiretroviral therapy (ART) but persistently low CD4+ T cell counts. Early identification …

Abstract Background World Health Organization (WHO) recommends that viral load ([VL) is
a primary tool that clinicians and researchers have used to monitor patients on antiretroviral …

P-selectin glycoprotein ligand-1 (PSGL-1) has been established to be a cell adhesion
molecule that is involved in the cellular rolling mechanism and the extravasation cascade …